Healius Limited (ASX:HLS)
Australia
· Delayed Price · Currency is AUD 0.630
-0.005 (-0.79%)
At close: Mar 6, 2026
Healius Revenue
Healius had revenue of 688.10M AUD in the half year ending December 31, 2025, with 10.84% growth. This brings the company's revenue in the last twelve months to 1.37B, up 5.99% year-over-year. In the fiscal year ending June 30, 2025, Healius had annual revenue of 1.34B with 5.69% growth.
Revenue (ttm)
1.37B
Revenue Growth
+5.99%
P/S Ratio
0.33
Revenue / Employee
229.79K
Employees
8,224
Market Cap
457.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.34B | 72.40M | 5.69% |
| Jun 30, 2024 | 1.27B | -435.10M | -25.49% |
| Jun 30, 2023 | 1.71B | -582.00M | -25.43% |
| Jun 30, 2022 | 2.29B | 374.70M | 19.57% |
| Jun 30, 2021 | 1.91B | 344.40M | 21.94% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Australian Clinical Labs | 737.49M |
| Monash IVF Group | 269.39M |
| Integral Diagnostics | 767.82M |
| Cryosite | 15.75M |
| Rhythm Biosciences | 1.65M |
| Microba Life Sciences | 14.90M |
| INOVIQ | 2.10M |
| BCAL Diagnostics | 2.54M |
Healius News
- 17 days ago - Healius Ltd (ASX:HLS) Half Year 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... - GuruFocus
- 17 days ago - Healius Limited (PHCRF) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Healius Limited (PHCRF) Shareholder/Analyst Call Transcript - Seeking Alpha